ANA Mª
GONZÁLEZ-PINTO ARRILLAGA
National Institute of Mental Health
Tokio, JapónPublikationen in Zusammenarbeit mit Forschern von National Institute of Mental Health (2)
2021
-
Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))
European Neuropsychopharmacology
-
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network
European Neuropsychopharmacology, Vol. 47, pp. 54-61